Published in Stroke on February 01, 1991
Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail (2008) 1.41
Solid-organ transplantation in older adults: current status and future research. Am J Transplant (2012) 1.33
Factors contributing to global cognitive impairment in heart failure: results from a population-based cohort. J Card Fail (2008) 1.28
Cognitive impairment in heart failure patients. J Geriatr Cardiol (2014) 1.25
Mammillary bodies and fornix fibers are injured in heart failure. Neurobiol Dis (2008) 1.12
Cognitive impairment in heart failure. Cardiol Res Pract (2012) 1.03
Longitudinal cognitive performance in older adults with cardiovascular disease: evidence for improvement in heart failure. J Cardiovasc Nurs (2009) 0.94
'Hearts and minds': association, causation and implication of cognitive impairment in heart failure. Alzheimers Res Ther (2015) 0.94
Cognitive profiles in heart failure: a cluster analytic approach. J Clin Exp Neuropsychol (2012) 0.89
Cognition in heart failure: an overview of the concepts and their measures. J Am Acad Nurse Pract (2011) 0.89
Geriatric conditions in heart failure. Curr Cardiovasc Risk Rep (2012) 0.84
Measurement of cognitive function in chronic heart failure: a feasibility study. Appl Nurs Res (2010) 0.81
Fortnightly review: anticoagulation in heart disease. BMJ (1999) 0.81
Sleep apnea and cognitive function in heart failure. Cardiovasc Psychiatry Neurol (2012) 0.79
Regional hippocampal damage in heart failure. Eur J Heart Fail (2015) 0.79
Cognitive decline in heart failure. Heart Fail Rev (2016) 0.78
Central nervous system changes in pediatric heart failure: a volumetric study. Pediatr Cardiol (2010) 0.78
Silent cerebral infarction in chronic heart failure: ischemic and nonischemic dilated cardiomyopathy. Vasc Health Risk Manag (2008) 0.78
Central and peripheral quadriceps fatigue in congestive heart failure. Int J Cardiol (2012) 0.77
Possible neurocognitive benefits of exercise in persons with heart failure. Eur Rev Aging Phys Act (2015) 0.75
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology (1993) 5.72
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Statins as immunomodulators: comparison with interferon-beta 1b in MS. Neurology (2002) 2.34
Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology (2005) 2.24
Determinants of brain iron in multiple sclerosis: a quantitative 3T MRI study. Neurology (2011) 2.11
Reversal by ceftriaxone of dilated cardiomyopathy Borrelia burgdorferi infection. Lancet (1992) 2.08
Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology (1988) 2.03
Improved neurological recovery of cerebral infarctions after plasmapheretic reduction of lipids and fibrinogen. Stroke (1993) 2.02
Oral treatment of late borreliosis with roxithromycin plus co-trimoxazole. Lancet (1990) 2.01
MRI criteria for MS in patients with clinically isolated syndromes. Neurology (2010) 1.90
White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors. Stroke (1988) 1.85
Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology (1993) 1.85
MRI white matter hyperintensities: three-year follow-up of the Austrian Stroke Prevention Study. Neurology (1999) 1.80
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
Improved diffusion-weighted single-shot echo-planar imaging (EPI) in stroke using sensitivity encoding (SENSE). Magn Reson Med (2001) 1.69
Neuropsychological studies in children with elevated tooth-lead concentrations. II. Extended study. Int Arch Occup Environ Health (1983) 1.69
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
Characteristics of patients registered for service at a neighborhood health center. Am J Public Health Nations Health (1970) 1.65
Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63
Filamentous bacterial viruses. I. DNA synthesis during the early stages of infection with fd. J Mol Biol (1971) 1.62
Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol (2009) 1.53
MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology (1999) 1.50
Diffusion-weighted imaging of patients with subacute cerebral ischemia: comparison with conventional and contrast-enhanced MR imaging. AJNR Am J Neuroradiol (2000) 1.49
Perforated ventricular aneurysm in a male suffering from pneumonia. Clin Cardiol (1991) 1.48
Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina. J Am Coll Cardiol (1990) 1.47
White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology (2004) 1.47
Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol (1992) 1.44
White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology (2010) 1.44
Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings. Stroke (1995) 1.43
Oxidative stress is associated with migraine and migraine-related metabolic risk in females. Eur J Neurol (2011) 1.42
Acupuncture using laser needles modulates brain function: first evidence from functional transcranial Doppler sonography and functional magnetic resonance imaging. Lasers Med Sci (2004) 1.37
Brain MRI findings and cognitive impairment in patients undergoing chronic hemodialysis treatment. J Neurol Sci (1995) 1.36
MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. Neurology (2006) 1.29
White matter changes in stroke patients. Relationship with stroke subtype and outcome. Eur Neurol (1999) 1.29
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes. Neurology (2010) 1.27
Role of magnetic resonance imaging within diagnostic criteria for multiple sclerosis. Ann Neurol (2004) 1.25
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology (1994) 1.24
Diffusion-weighted imaging with navigated interleaved echo-planar imaging and a conventional gradient system. Radiology (1999) 1.20
MR of cerebral abnormalities concomitant with primary intracerebral hematomas. AJNR Am J Neuroradiol (1996) 1.20
The Causative Classification of Stroke system: an international reliability and optimization study. Neurology (2010) 1.19
Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med (2000) 1.19
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Assessment of MRI criteria for a diagnosis of MS. Neurology (1993) 1.17
Apolipoprotein E e4 allele in the normal elderly: neuropsychologic and brain MRI correlates. Clin Genet (1996) 1.17
Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology (2012) 1.17
The morphologic correlate of incidental punctate white matter hyperintensities on MR images. AJNR Am J Neuroradiol (1991) 1.15
Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis. Mult Scler (2009) 1.11
Simple versus complex assessment of white matter hyperintensities in relation to physical performance and cognition: the LADIS study. J Neurol (2006) 1.10
Role of white matter lesions in cognitive impairment of vascular origin. Alzheimer Dis Assoc Disord (2000) 1.08
Frequency and location of microbleeds in patients with primary intracerebral hemorrhage. Stroke (2000) 1.05
MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology (2009) 1.04
Clinical significance of corpus callosum atrophy in a mixed elderly population. Neurobiol Aging (2006) 1.04
Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04
Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis. J Neurol (2012) 1.04
Nuclear magnetic resonance image white matter lesions and risk factors for stroke in normal individuals. Stroke (1988) 1.02
A correlation of clinical findings and CT in ischaemic cerebrovascular disease. Eur Neurol (1979) 1.02
The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease. J Neurol Sci (1996) 1.01
Magnetic resonance imaging of cerebral microbleeds. Curr Opin Neurol (2000) 1.00
EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol (2010) 1.00
Peripheral facial palsy: etiology, diagnosis and treatment. Eur Neurol (1999) 1.00
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Mult Scler (2010) 0.98
Magnetic resonance imaging correlates of transient cerebral ischemic attacks. Stroke (1996) 0.98
A recommended treatment algorithm in relapsing multiple sclerosis: report of an international consensus meeting. Eur J Neurol (2006) 0.97
APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers. Neurology (2006) 0.97
EFNS guidelines on the use of neuroimaging in the management of multiple sclerosis. Eur J Neurol (2006) 0.97
Cerebral atrophy as outcome measure in short-term phase 2 clinical trials in multiple sclerosis. Neuroradiology (2010) 0.97
White matter changes contribute to corpus callosum atrophy in the elderly: the LADIS study. AJNR Am J Neuroradiol (2008) 0.97
Assessment of cerebrovascular risk profiles in healthy persons: definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology (1994) 0.97
Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J Am Geriatr Soc (1996) 0.96
Medial temporal lobe atrophy and white matter hyperintensities are associated with mild cognitive deficits in non-disabled elderly people: the LADIS study. J Neurol Neurosurg Psychiatry (2005) 0.96
Superficial siderosis of the central nervous system: MRI findings and clinical significance. Neuroradiology (1996) 0.96
Lack of association of lobar intracerebral hemorrhage with apolipoprotein E genotype in an unselected population. Cerebrovasc Dis (2006) 0.95
Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study. J Neurol Neurosurg Psychiatry (2009) 0.95
Increased nitric oxide stress is associated with migraine. Cephalalgia (2010) 0.94
Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol (1991) 0.94